Works matching Eli Lilly

Results: 5000

Les synchronicités historiques de la Chaire Eli Lilly Canada de recherche en schizophrénie.

Published in:

Sante Mentale au Quebec, 2024, v. 49, n. 2, p. 271, doi. 10.7202/1114414ar

By:

Potvin, Stéphane;
Stip, Emmanuel

Publication type:

Article

Eli Lilly increases funds for global TB/MDR-TB partnership.

Published in:: 2007
Publication type:: Other

Eli Lilly and the International Investment Law Challenge to a Neo-Federal IP Regime.

Published in:

Vanderbilt Journal of Entertainment & Technology Law, 2018, v. 21, n. 2, p. 517

By:

Yackee, Jason;
Ghosh, Shubha

Publication type:

Article

Eli Lilly wins race to take control of ImClone.

Published in:: Nature, 2008, v. 455, n. 7214, p. 719, doi. 10.1038/455719d
Publication type:: Article

Eli Lilly Letter Warns Against Taking Tirzepatide for "Cosmetic Weight Loss".

Published in:

Patient Care (Online), 2024, p. 4

By:

Halsey, Grace

Publication type:

Article

THE PREHISTORY OF MR. ELI LILLY.

Published in:

Southeastern Archaeology, 2012, v. 31, n. 2, p. 131, doi. 10.1179/sea.2012.31.2.001

By:

Peebles, Christopher S.

Publication type:

Article

Eli Lilly and Company:At the Forefront of a New Era in Cancer Discovery.

Published in:: ONS News, 2003, v. 18, n. 12, p. 11
Publication type:: Article

Probability Assessments to Support Portfolio Management at Eli Lilly.

Published in:

Foresight: The International Journal of Applied Forecasting, 2025, n. 76, p. 6

By:

PERSINGER, CHARLES;
ANDERSEN, JAY

Publication type:

Article

Eli Lilly extends funding and support for global TB/MDR-TB partnership.

Published in:: 2008
Publication type:: Other

Reexamining Eli Lilly v. Canada: A Human Rights Approach to Investor-State Disputes?

Published in:

Vanderbilt Journal of Entertainment & Technology Law, 2018, v. 21, n. 2, p. 437

By:

Ho, Cynthia M.

Publication type:

Article

Eli Lilly agrees to acquire Novartis Animal Health.

Published in:: Veterinary Record: Journal of the British Veterinary Association, 2014, v. 174, n. 17, p. 417, doi. 10.1136/vr.g2893
Publication type:: Article

Eli Lilly.

Published in:

Business & Society Review (00453609), 1994, n. 88, p. 70

By:

Moskowitz, Milton R.

Publication type:

Article

How Eli Lilly Fixed a Broken Performance Management System.

Published in:

People & Strategy, 2016, v. 39, n. 3, p. 11

By:

Becker, Deborah

Publication type:

Article

A Hard Pill to Swallow: A Critical Look at Eli Lilly & Co.'s NAFTA Challenge of the Canadian Patent Regime, and Its Potential Side Effects.

Published in:

International Lawyer, 2013, v. 47, n. 3, p. 519

By:

HAKERT II, J. DAMIAN

Publication type:

Article

Ariad Pharmaceuticals Wins First Round Over Eli Lilly, Patents on Methods Can Be Far-reaching.

Published in:

JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 15, p. 1028, doi. 10.1093/jnci/djj340

By:

Mack, George S.

Publication type:

Article

Eli Lilly invests US$1bn in Irish expansion.

Published in:: TCE: The Chemical Engineer, 2024, n. 1000, p. 6
Publication type:: Article

Eli Lilly pays IChemE fees for Irish students.

Published in:: TCE: The Chemical Engineer, 2014, n. 882, p. 19
Publication type:: Article

Eli Lilly wins Alzheimer's antibody patent dispute.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 656, doi. 10.1038/nrd4122
Publication type:: Article

Eli Lilly and Company's bioethics framework for human biomedical research.

Published in:

2015

By:

Van Campen, Luann E.;
Therasse, Donald G.;
Klopfenstein, Mitchell;
Levine, Robert J.

Publication type:

journal article

Eli Lilly launches new antidepressant Cymbalta for treating MDD.

Published in:: Brown University Psychopharmacology Update, 2004, v. 15, n. 10, p. 1
Publication type:: Article

Eli Lilly Studying Two Novel Drugs For Depression.

Published in:: Brown University Psychopharmacology Update, 1999, v. 10, n. 9, p. 7
Publication type:: Article

Eli Lilly Open Letter Warns Against Use of Tirzepatide for "Cosmetic Weight Loss".

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

FSP Relationships: i3 Statprobe and Eli Lilly.

Published in:

Applied Clinical Trials, 2011, p. 15

By:

Henderson, Lisa

Publication type:

Article

Efsitora Alfa, Eli Lilly's Once Weekly Insulin, Has Positive Topline Results in Two Trials.

Published in:: Patient Care (Online), 2024, p. 1
Publication type:: Article

Donanemab FDA AdComm Hearing Scheduled for June 10, Eli Lilly Says.

Published in:: Patient Care (Online), 2024, p. 1
Publication type:: Article

ENCOURAGING FURTHER INNOVATION: ARIAD v. ELI LILLY AND THE WRITTEN DESCRIPTION REQUIREMENT.

Published in:

Seton Hall Law Review, 2012, v. 42, n. 3, p. 1287

By:

Jakas, Joseph

Publication type:

Article

Eli Lilly to buy Novartis' animal health unit for $5.4bn.

Published in:: Veterinary Ireland Journal, 2014, v. 4, n. 5, p. 238
Publication type:: Article

IMMATERIAL TO INNOVATION: THE STORY OF ARIAD PHARMACEUTICALS, INC. V. ELI LILLY & CO.

Published in:

Brooklyn Journal of Corporate, Financial & Commercial Law, 2011, v. 5, n. 2, p. 503

By:

Kimmelblatt, Brian

Publication type:

Article

Products Liability--DES--Kortenhaus v. Eli Lilly & Co.

Published in:: American Journal of Law & Medicine, 1989, v. 15, n. 1, p. 143
Publication type:: Article

On Eli Lilly's Decision to Lower the Starter Price of Blockbuster Weight-Loss Drug Zepbound.

Published in:

CounterPunch, 2024, p. 1

By:

Sanders, Bernie

Publication type:

Article

Capsule Case: Eli Lilly Abroad.

Published in:

Public Relations Quarterly, 1966, v. 11, n. 2, p. 39

By:

Richards, David R.

Publication type:

Article

Eli Lilly and Company Uses Integer Programming to Form Volunteer Teams in Impoverished Countries.

Published in:

Interfaces, 2013, v. 43, n. 3, p. 268, doi. 10.1287/inte.2013.0679

By:

Mahar, Stephen;
Winston, Wayne;
Wright, P. Daniel

Publication type:

Article

Takeda and Eli Lilly Announce A Cardiovascular Outcome Study with Pioglitazone.

Published in:: Diabetes, Obesity & Metabolism, 2001, v. 3, n. 2, p. 123
Publication type:: Article

Eli Lilly supports generics.

Published in:: Australian Journal of Pharmacy, 2012, v. 93, n. 1105, p. 42
Publication type:: Article

Cast back into the sea of uncertainty--A doctrine of equivalents in UK law? The Supreme Court ruling in Actavis v Eli Lilly.

Published in:

Journal of Intellectual Property Law & Practice, 2018, v. 13, n. 7, p. 564, doi. 10.1093/jiplp/jpx226

By:

Jadeja, Nicole;
Smith-Willis, Hannah;
Hurdle, Heidi

Publication type:

Article

STATEMENT FROM ELI LILLY AND COMPANY REGARDING APPROVAL RECOMMENDATION FROM FDA ADVISORY COMMITTEE FOR EXPANDING THE PAIN INDICATIONS FOR CYMBALTA TO A BROADER PAIN POPULATION.

Published in:: Psychiatry (1550-5952), 2010, v. 7, n. 8, p. 9
Publication type:: Article

Patent law--medical device experimental use exception in patent infringement: Eli Lilly v....

Published in:

1991

By:

Rathe, Todd A.

Publication type:

Editorial

Eli Lilly (Book).

Published in:

1991

By:

Walsh, Margaret

Publication type:

Book Review

Eli Lilly: A Life, 1885-1977 (Book).

Published in:

1990

By:

Ingham, John N.

Publication type:

Book Review

The Brüstle and Eli Lilly cases: Creation--God or humankind?

Published in:

Oxford Journal of Law & Religion, 2012, v. 1, n. 2, p. 518, doi. 10.1093/ojlr/rws009

By:

GILES, JESSICA

Publication type:

Article

Eli Lilly Expands Zepbound Access with New Vial Doses, Self-Pay Savings.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

Eli Lilly and AstraZeneca to Co-Develop MEDI1814 as Disease-Modifying Treatment for Alzheimer's Disease.

Published in:: Journal of Gerontological Nursing, 2017, v. 43, n. 3, p. 5
Publication type:: Article

Products Liability--Statute of Limitations--Yustich v. Eli Lilly.

Published in:: American Journal of Law & Medicine, 1984, v. 9, n. 4, p. 523
Publication type:: Article

In the Circle: Eli Lilly & Company Excellent Preceptor Award.

Published in:: 2006
Publication type:: Excerpt

Becoming a premier partner: Measuring, managing and changing partnering capabilities at Eli Lilly and Company.

Published in:

Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 5, doi. 10.5912/jcb407

By:

Futrell, David;
Slugay, Marlene;
Stephens, Carol H.

Publication type:

Article

Eli Lilly enters venture capital arena.

Published in:

Nature Biotechnology, 2001, v. 19, n. 11, p. 997, doi. 10.1038/nbt1101-997

By:

Fletcher, Liz

Publication type:

Article

Eli Lilly clarifies Mounjaro availability.

Published in:: Australian Journal of Pharmacy, 2025, v. 106, n. 1246, p. 13
Publication type:: Article

Gold(I)-Catalyzed Cyclizations of Silyl Enol Ethers: Application to the Synthesis of (+)-Lycopladine AWe gratefully acknowledge the University of California, Berkeley, NIHGMS (R01 GM073932-01), Merck Research Laboratories, Bristol-Myers Squibb, Amgen Inc., DuPont, GlaxoSmithKline, Eli Lilly & Co., Pfizer, AstraZeneca, and Roche for financial support. J.J.K.-S. thanks Eli Lilly & Co. for a graduate fellowship. We thank Lauren A. Young for the preparation of tributylallenylstannane.

Published in:

Angewandte Chemie, 2006, v. 118, n. 36, p. 6137, doi. 10.1002/ange.200602035

By:

Steven T. Staben;
Joshua J. Kennedy-Smith;
David Huang;
Britton K. Corkey;
Rebecca L. LaLonde;
F. Dean Toste

Publication type:

Article

An assessment of the UK approach to parametric claims after Actavis v Eli Lilly.

Published in:

Journal of Intellectual Property Law & Practice, 2021, v. 16, n. 2, p. 109, doi. 10.1093/jiplp/jpaa210

By:

Gribanov, Ilya

Publication type:

Article

Litigating patents in investment arbitration: Eli Lilly v Canada.

Published in:

Journal of Intellectual Property Law & Practice, 2017, v. 12, n. 10, p. 815, doi. 10.1093/jiplp/jpx153

By:

Lentner, Gabriel M.

Publication type:

Article